Selected Lab Publications
Selected publications by Dr. Zeifman & colleagues.
For a full list of Dr. Zeifman’s publications, please see his Google Scholar page or ResearchGate profile.
Index
Does psychedelic-assisted therapy work and is it safe?
Petridis et al. (2024)
Psilocybin-assisted psychotherapy improves psychiatric symptoms in patients with cancer
Nature Mental Health
Pagni et al. (2025)
Multi-dimensional Personality Changes Following Psilocybin-Assisted Therapy in AUD
American Journal of Psychiatry
Marrocu et al. (2024)
Psychiatric risks for worsened mental health after psychedelic use
Journal of Psychopharmacology
Zeifman et al. (2023)
Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences
Scientific Reports
Timmermann et al. (2024)
Effects of DMT on mental health outcomes in healthy volunteers
Scientific Reports
Zeifman et al. (2022)
Decreases in suicidality following psychedelic therapy: A meta-analysis of individual patient data across clinical trials
The Journal of Clinical Psychiatry
Zeifman et al. (2021)
On the relationship between classic psychedelics and suicidality: A systematic review
ACS Pharmacology & Translational Science
Ross et al. (2021)
Acute and sustained reductions in loss of meaning and suicidal ideation following psilocybin-assisted psychotherapy for psychiatric and existential distress in life-threatening cancer
ACS Pharmacology & Translational Science
Zeifman et al. (2021)
Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: Results from an open-label trial
Psychopharmacology
Zeifman et al. (2019)
The impact of ayahuasca on suicidality: Results from a randomized controlled trial
Frontiers in Pharmacology
Meshkat et al. (2025)
Efficacy and safety of psilocybin for substance use disorders: A systematic review
Neuroscience & Biobehavioral Reviews
Meshkat et al. (2025)
Psychedelics and Suicide-Related Outcomes: A Systematic Review
Journal of Clinical Medicine
How does psychedelic-assisted therapy work?
Zeifman et al. (2025)
From relaxed beliefs under psychedelics (REBUS) to revised beliefs after psychedelics (REBAS)
Scientific Reports
Agin-Liebes, Zeifman & Mitchell (2025)
Self-compassion mediates treatment effects in MDMA-assisted therapy for PTSD
European Journal of Psychotraumatology
Sloshower et al. (2024)
Psychological flexibility as a mechanism of change in psilocybin therapy for depression
Scientific Reports
Zeifman et al. (2024)
Preliminary evidence for the importance of therapeutic alliance in MDMA-assisted psychotherapy
European Journal of Psychotraumatology
Zeifman et al. (2023)
How does psilocybin therapy work? An exploration of experiential avoidance
Journal of Affective Disorders
Carhart-Harris et al. (2023)
Canalization and plasticity in psychopathology
Neuropharmacology
Agin-Liebes et al. (2022)
Prospective examination of the therapeutic role of psychological flexibility and cognitive reappraisal in the ceremonial use of ayahuasca
Journal of Psychopharmacology
Murphy et al. (2022)
Therapeutic alliance and rapport modulate responses to psilocybin assisted therapy for depression
Frontiers in Pharmacology
Zeifman et al. (2020)
Post-psychedelic reductions in experiential avoidance are associated with decreases in depression severity and suicidal ideation
Frontiers in Psychiatry
For whom does psychedelic-assisted therapy work?
Zeifman & Wagner (2020)
Exploring the case for research on incorporating psychedelics within interventions for borderline personality disorder
Journal of Contextual Behavioral Science
Gordon et al. (in press)
The Effect of Psychedelics on Individuals with a Personality Disorder
Psychedelic Medicine
Carrithers et al. (2025)
Exploring serotonergic psychedelics as a treatment for personality disorders
Neuropharmacology
Gold et al. (2023)
Exploring the Potential Utility of Psychedelic Therapy for Patients With ALS
Journal of Palliative Medicine
Zeifman et al. (2025)
Ceremonial Psychedelic Experiences and Changes in Mental Health Outcomes in Those with Adverse Childhood Experiences
Psychedelic Medicine
Protocols
Wagner et al. (2025)
Protocol for a Phase 2 Open-Label Pilot Study of MDMA-Assisted CPT for PTSD
The Behavior Therapist
Meshkat, Zeifman et al. (2025)
Psilocybin-assisted massed CPT for chronic PTSD: Protocol for an open-label trial
PLOS One
Additional publications of interest
Meshkat et al. (2025)
Therapeutic Effects of Low-Dose Psilocybin in Depression: A Systematic Review
Psychedelic Medicine
Meshkat et al. (2025)
Pharmacokinetics of Psilocybin: A Systematic Review
Pharmaceutics
Wen et al. (2024)
A systematic review of study design and placebo controls in psychedelic research
Psychedelic Medicine
Zeifman & Maia (2024)
Methodological concerns in psychedelic research
European Neuropsychopharmacology
Zeifman et al. (2022)
RElaxed Beliefs-Questionnaire (REB-Q) and REB-Q Self-Report (REB-Q-SR): Administration manual
PsyArXiv
Traynor et al. (2022)
MDMA-assisted psychotherapy for borderline personality disorder
Focus
